Biogen Inc is a biotechnology company based in Cambridge, Massachusetts, that discovers, develops and markets medicines for serious neurological and neurodegenerative conditions. Its products treat multiple sclerosis, spinal muscular atrophy and Alzheimer's disease, and it also offers biosimilar medicines. Its customers are mainly hospitals, specialist physicians and healthcare providers, with sales concentrated in the United States and other developed markets. The company also runs research programmes in neurology and immunology.
Biogen Inc is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code BIIB34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #115 of 1454 on the Sao Paulo Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendStrong
88/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average15.4%
From 52-week high0.0%
MomentumStrong
84/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return13.8%
6-month return30.1%
12-month, skipping last month44.8%
Stability (higher is calmer)Strong
80/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)29.5%
Worst drawdown, 1 year (smaller is calmer)-13.9%
LiquidityWeak
13/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.00M BRL
Zero-volume days83.3%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
52-wk range 128.69 – 193.80Daily closes, split-adjusted
Signals
50-day average185.45
200-day average167.99
Golden/death cross (60d)None
New 52-week highYes
Bullish RSI divergenceNo
Average daily range (ATR)0.77
Technical summary
Daily
Bullish
12 bullish · 0 neutral · 4 bearish
Weekly
Strongly bullish
11 bullish · 0 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
188.9
Bullish
EMA 10
189.6
Bullish
SMA 20
188.5
Bullish
EMA 20
188.6
Bullish
SMA 50
185.4
Bullish
EMA 50
184.9
Bullish
SMA 100
176.7
Bullish
EMA 100
178.5
Bullish
SMA 200
168.0
Bullish
EMA 200
169.9
Bullish
Oscillators (daily)
RSI (14)
79.91
Bearish
MACD (12, 26)
1.32
Bullish
Momentum (12)
2.93
Bullish
Stochastic %K (14)
100.0
Bearish
Williams %R (14)
0.00
Bearish
CCI (20)
333.3
Bearish
Pivot points (classic, last session)
S3
193.8
S2
193.8
S1
193.8
Pivot
193.8
R1
193.8
R2
193.8
R3
193.8
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in BRL. Educational only, not financial advice.
